Production of 2 Excedrin migraine products suspended [FOX News]
GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
US:NYSE Investor Relations:
gsk.com/en-gb/investors
Company Research
Source: FOX News
close Video Fox News Flash top headlines for Jan. 22 Fox News Flash top headlines for Jan. 22 are here. Check out what's clicking on Foxnews.com Migraine two popular Excedrin products In a statement sent to Fox News, the company said it was not recalling either Excedrin Extra Strength Caplets and Geltabs or Excedrin Migraine Caplets and Geltabs, but that it had discovered “inconsistencies in how we transfer and weigh ingredients” in the products, and was temporarily suspending production and distribution. FLU VACCINE IN PILL FORM ON HORIZON “Based on available data, GSK believes that the product does not pose a safety risk to consumers,” a GSK spokesperson said via email. “However, as a precautionary measure, GSK Consumer Healthcare has voluntarily implemented a temporary discontinuation of production and distribution.” While the company did not say when it expects to resume production, the spokesperson said it is a “short term issue.” CORONAVIRUS VACCINE IN 'EARLY STAGES' AS FOCUS TU
Show less
Read more
Impact Snapshot
Event Time:
GSK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GSK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GSK alerts
High impacting GSK plc American Depositary Shares (Each representing two Ordinary Shares) news events
Weekly update
A roundup of the hottest topics
GSK
News
- GSK Trades At Low Price Multiples, But Its Pipeline Needs To Improve [Seeking Alpha]Seeking Alpha
- 12 Best Biotech Penny Stocks to Invest In [Yahoo! Finance]Yahoo! Finance
- Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancerBusiness Wire
- GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising RiseBusiness Wire
- GSK plc (NYSE: GSK) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating.MarketBeat
GSK
Sec Filings
- 4/19/24 - Form 6-K
- 4/17/24 - Form 6-K
- 4/17/24 - Form 6-K
- GSK's page on the SEC website